Literature DB >> 20837346

First clinical experience of Ankaferd BloodStopper as a hemostatic agent in partial nephrectomy.

Emre Huri1, Turgay Akgül, Ali Ayyildiz, Murat Bağcioğlu, Cankon Germiyanoğlu.   

Abstract

Open partial nephrectomy is an effective and safe alternative treatment modality to radical nephrectomy for small renal tumors. Many techniques that use hemostatic agents have been described to provide hemostasis during this procedure. Ankaferd BloodStopper® (ABS) is a unique folkloric medicinal plant extract that has been used historically in Turkish traditional medicine as a hemostatic agent. ABS has therapeutic potential to manage hemorrhage and this agent should be investigated in clinical trials. In the present case, we evaluated the effectiveness of ABS in partial nephrectomy and reviewed the literature.
Copyright © 2010 Elsevier. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20837346     DOI: 10.1016/S1607-551X(10)70077-2

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  5 in total

1.  Massive haematuria successfully managed by intravesical Ankaferd in a haemodialysis patient complicated with disseminated intravascular coagulation.

Authors:  Yalcin Solak; Abduzhappar Gaipov; Orhan Ozbek; Mustafa Aziz Hassan; Mehdi Yeksan
Journal:  BMJ Case Rep       Date:  2012-12-23

2.  Beneficial effects of Ankaferd Blood Stopper on dermal wound healing: an experimental study.

Authors:  Cagri Akalin; Serdar Kuru; Aziz Mutlu Barlas; Kemal Kismet; Bugra Kaptanoglu; Aydin Demir; Hesna Muzeyyen Astarci; Huseyin Ustun; Ertugrul Ertas
Journal:  Int Wound J       Date:  2012-09-03       Impact factor: 3.315

3.  Ultrastructural analyses of the novel chimeric hemostatic agent generated via nanotechnology, ABS nanohemostat, at the renal tissue level.

Authors:  Emre Huri; Engin Dogantekin; Murvet Hayran; Umit Yavuz Malkan; Mine Ergun; Aysegul Firat; Yavuz Beyazit; Huseyin Ustun; Murat Kekilli; Mumtaz Dadali; Muzeyyen Astarci; Ibrahim C Haznedaroglu
Journal:  Springerplus       Date:  2016-11-08

4.  Generation of Chimeric "ABS Nanohemostat" Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model.

Authors:  Emre Huri; Yavuz Beyazit; Rashad Mammadov; Sila Toksoz; Ayse B Tekinay; Mustafa O Guler; Huseyin Ustun; Murat Kekilli; Mumtaz Dadali; Tugrul Celik; Müzeyyen Astarci; Ibrahim C Haznedaroglu
Journal:  Int J Biomater       Date:  2013-02-20

Review 5.  Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper).

Authors:  Rafiye Ciftciler; Ali Erdinc Ciftciler; Umit Yavuz Malkan; Ibrahim C Haznedaroglu
Journal:  SAGE Open Med       Date:  2020-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.